Abstract Portal is Now Closed
Let your mentors and peers hear from you next March! Showcase your original research by presenting an abstract at Translational Science 2019. It's the ideal place to highlight your expertise, engage key thought leaders, and facilitate discussions for funding and collaboration.
Abstracts can be evaluated for both poster and distinguished oral abstract presentations based on your preference. (Please note: You must be registered for your abstract to be accepted.)
- September 25: Call for Abstracts Opens
- November 30: Call for Abstracts Closes
- Early January: Individuals Notified of Their Acceptance Status
Abstracts submitted for Translational Science 2019 may represent work in progress or previously published research. If you wish for your abstract to be considered for publication, it must be original research, not published previously and not being considered for publication elsewhere. Edits may be made up until the submission portal closes.
All abstracts must meet the following requirements:
- Title (255 character limit, including spaces)
- Research Overview (1500 character limit, including spaces)
- Methods/Study Population
- Results/Anticipated Results
- Discussion/Significance of Impact
- Grant Numbers/Other Funding Source (if funded)
- Authors' Conflict of Interest
Abstracts must align with the following Translational Science tracks:
- Basic Science; Methodology
- Biomedical Informatics; Health Informatics
- Clinical Epidemiology; Clinical Trial
- Commercialization; Entrepreneurship; Regulatory Science
- Digital Health; Social Media; Artificial Intelligence (AI)
- Education; Mentoring; Professional and Career Development
- Health Equity; Community Engagement
- Mechanistic Basic to Clinical
- Regulatory Science; Translational Methods
- Team Science
- Translational Science; Policy and Health Outcomes Science
Submitted abstracts may also be published in the Journal of Clinical and Translational Science (JCTS) and must adhere to the following guidelines:
- Submitted abstracts must be an original contribution and may not be under consideration for publication elsewhere.
- Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and reviewers make every effort to ensure the validity of published abstracts, the final responsibility rests with the authors and not with the ACTS, AFMR, CR Forum, or JCTS.
- Additional information regarding the publication of manuscripts in JCTS can be found at the Cambridge University Press.
Burroughs Wellcome Fund Travel Award
Since 2009, the Burroughs Wellcome Fund has generously supported early career scholars and pre-doctoral trainees to take part in the Translational Science Annual Meeting. This grant is intended to support trainee travel to Translational Science 2019, March 5-8 in Washington, DC.
The Burroughs-Wellcome Fund is an independent private foundation dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities. Within this broad mission, BWF has two primary goals:
- To help scientists early in their careers develop as independent investigators
- To advance fields in the basic biomedical sciences that are undervalued or in need of particular encouragement
BWF’s financial support is channeled primarily through competitive, peer-reviewed award programs.
In order to be considered for a BWF Award, the primary author must be a trainee and upload a CV during the abstract submission process. Applicants that are not trainees or applications without CVs will not be considered.
To apply, select the option labeled "Burroughs Wellcome" during the abstract submission process.
If you have any questions about the abstract submission process, please email firstname.lastname@example.org.